Latest Forum Topics /
Medtecs Intl
Last:0.122
-0.001
|
|
|
The next journey
|
|||||
|
TodaySgCny
Senior |
08-May-2021 16:38
|
||||
|
x 0
x 0 Alert Admin |
Covid cases increasing in most part of countries,sooner medical stock will be back in play with a bang.BB collecting cheap from weak holder.Medtec and Sri Trang will hopefully meet each other in same price once again. | ||||
| Useful To Me Not Useful To Me | |||||
|
tonyja
Elite |
08-May-2021 14:36
|
||||
|
x 0
x 0 Alert Admin |
The disadvantage is they trade at Sgx n tagged with glove counters. So one way or another , they r dragged by glove 
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Blowyouoff
Veteran |
08-May-2021 14:30
|
||||
|
x 0
x 0 Alert Admin |
Bro, all the vaccines company didn' t promise 100% success rate.. what we are seeing are expected base on published result. This few numbers happened to be those few % who are not protected despite being vaccinated. One of the reason why they are protected despite being vaccinated could be their body did not produce sufficient antibodies.  also, there wil be more asymptomatic cases once they do more routine screening. Vaccinated patients could potentially be carrier but because of the vaccination, they do not present symptoms(this is one of the main objective of the vaccination which is to prevent us from having the symptoms)
|
||||
| Useful To Me Not Useful To Me | |||||
|
tonyja
Elite |
08-May-2021 12:44
|
||||
|
x 0
x 0 Alert Admin |
WHO gives emergency approval to Sinopharm, first Chinese COVID-19 vaccine07 May 2021 11:34PM
Asia
A general practitioner opens a packet containing vials of China' s Sinopharm COVID-19 vaccine on Mar 25, 2021. (Photo: AP/MTI/Attila Balazs) (Updated:  08 May 2021 12:11AM)
BookmarkGENEVA: The World Health Organization announced on Friday (May 7) it had approved a COVID-19 vaccine from China' s state-owned drugmaker Sinopharm for emergency use. The vaccine, one of two main Chinese shots that collectively have already been given to hundreds of millions of people in China and abroad, becomes the first COVID-19 shot developed by a non-Western country to win the WHO' s backing. READ:  Sinovac COVID-19 vaccine effective but some data lacking: WHO expertsIt is also the first time the WHO has given emergency use approval to any Chinese vaccine for any infectious disease. A WHO emergency listing is a signal to national regulators on a product' s safety and efficacy, and would allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries. " This afternoon, WHO gave emergency use listing to Sinopharm Beijing' s COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality," the UN health agency' s director-general Tedros Adhanom Ghebreyesus told a news conference. Tedros also said that a separate expert panel has recommended two doses of Sinopharm vaccine for those aged 18 and above.  The WHO has previously given emergency approval to COVID-19 vaccines developed by Pfizer-BioNTech, AstraZeneca, Johnson & Johnson, and, last week, Moderna. READ:  On vaccinating the globe, Blinken warns: ' We have to speed this up'The decision to approve Sinopharm' s vaccine was taken by WHO' s technical advisory group, which began meeting on Apr 26 to review the latest clinical data as well as Sinopharm' s manufacturing practices. A separate group of WHO experts, the Strategic Advisory Group of Experts (SAGE), voiced concern this week over data provided by Sinopharm on the risk of serious side-effects in some patients, but was confident in the vaccine' s ability to prevent disease, according to a document reviewed by Reuters. SAGE found an efficacy of 78.1 per cent after two doses in multi-country Phase III clinical trials, according to the document. The vaccine' s developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group, had announced an efficacy of 79.34 per cent. READ:  EU regulator reviews reports of rare nerve disorder after AstraZeneca shotThe WHO has said it could reach a decision on China' s other main COVID-19 vaccine, made by Sinovac Biotech, as soon as next week. The technical experts reviewed it on Wednesday. China has deployed around 65 million doses of the Sinopharm vaccine and more than 200 million doses of the Sinovac shot. Both have been exported to many countries, particularly in Latin America, Asia and Africa, many of which have had difficulty securing supplies of vaccines developed in the West. |
||||
| Useful To Me Not Useful To Me | |||||
|
Sgsw0chh
Member |
08-May-2021 12:13
|
||||
|
x 0
x 0 Alert Admin |
Medtec has been holding firm at 0.93 since 7 Dec 2020. If it break at 0.93 next week, the next support is 0.865. It may reach hibernation between 0.865 to 0.93 until next quarter result when 0.93 resistance could be cleared to reach $1 gradually. Good luck guys!!!
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Abe2021
Veteran |
08-May-2021 10:15
|
||||
|
x 0
x 0 Alert Admin |
" Today, India is in the midst of a deadly second wave of the pandemic with no relief in sight," writes Subramanya. https://asia.nikkei.com/Opinion/Narendra-Modi-s-COVID-catastrophe-brings-India-to-its-knees The demand will continue to be strong till end of 2021 |
||||
| Useful To Me Not Useful To Me | |||||
|
des_khor
Supreme |
08-May-2021 09:30
Yells: "Tell me who is God or Market Fortune Teller in this forum ??" |
||||
|
x 0
x 0 Alert Admin |
Think the vaccine not effective as we can see local case from TTSH how many of them are doctors and nurses who already received 2 doses ! | ||||
| Useful To Me Not Useful To Me | |||||
|
Shifu8888
Supreme |
08-May-2021 09:27
|
||||
|
x 0
x 0 Alert Admin |
Bot on dip yesterday and made 6/7 bids. Not vested now but I am sure ppe stocks will make a big comeback. I had said vaccine is not going to help contain the COVID. It is gonna be a wild geese chase. Pfizer NOT effective against fiery Indian Variant.
https://sg.news.yahoo.com/vaccinated-american-doctor-dies-travelling-231602154.html |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
zandlery
Supreme |
07-May-2021 23:09
|
||||
|
x 0
x 0 Alert Admin |
Now the question is whether BB will still include medtec as the big 4 to move as pandemic stocks. Since it different product from them and revenue sort of drop faster than the rest.
If still move together as trend can try to catch the bottom and grab some for future bet. If no, well..... |
||||
| Useful To Me Not Useful To Me | |||||
|
ETLee8
Master |
07-May-2021 23:09
|
||||
|
x 0
x 0 Alert Admin |
Yes, worth waiting to collect 4.18 cts (usd).  No more chance going forward as this quarter earnings only 2.4cts (usd).  For whole year may be less than 10 cts (usd) assuming consistent profit for the next 3 quarters.  Next year may be 5 cts eps.   
|
||||
| Useful To Me Not Useful To Me | |||||
|
Blue_Dragon
Member |
07-May-2021 21:41
|
||||
|
x 0
x 0 Alert Admin |
Short Sellers dominating? They will need to cover back their positions.
Hopefully we can see a 5%-8% up in a day. 😜
|
||||
| Useful To Me Not Useful To Me | |||||
|
SgYuan
Supreme |
07-May-2021 21:35
|
||||
|
x 0
x 0 Alert Admin |
goggle Elliott wave
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
shareabc
Member |
07-May-2021 21:34
|
||||
|
x 0
x 0 Alert Admin |
bro, can help to interpret it?
|
||||
| Useful To Me Not Useful To Me | |||||
|
SgYuan
Supreme |
07-May-2021 21:28
|
||||
|
x 0
x 0 Alert Admin |
1h chart ew on w2/w3 
|
||||
| Useful To Me Not Useful To Me | |||||
|
SgYuan
Supreme |
07-May-2021 21:26
|
||||
|
x 0
x 0 Alert Admin |
zoom out px move back up to above the lower trendline 
|
||||
| Useful To Me Not Useful To Me | |||||
|
SgYuan
Supreme |
07-May-2021 21:24
|
||||
|
x 0
x 0 Alert Admin |
over corrected below the lower trendline px hit low 935 this cause the push up to 1010 ![]()   |
||||
| Useful To Me Not Useful To Me | |||||
|
sweet639
Veteran |
07-May-2021 21:05
|
||||
|
x 0
x 0 Alert Admin |
cross my finger & hope next Monday can go up, as 11/5/21 is last day for US$0.418 dividend,
|
||||
| Useful To Me Not Useful To Me | |||||
|
Abe2021
Veteran |
07-May-2021 20:57
|
||||
|
x 0
x 0 Alert Admin |
If you talk about during the pandemic in 2020, the cost of raw material also went up crazy. The have partnership with Mytrex to ensure cost effective and reliable supply of critical raw materials for PPE.  Build a resilient supply chain. Medtecs Shield Anti-Viral Collection Share buy back R& D Centre Of course the move over to mainboard. Dyodd |
||||
| Useful To Me Not Useful To Me | |||||
|
zandlery
Supreme |
07-May-2021 20:28
|
||||
|
x 0
x 0 Alert Admin |
Revenue actually drop if compare to Q4 2020 I think.
No much change on Q1 2021 compare to Q1 2020 but last year Q1 actually shld be the lowest in income as the pandemic more or less break out after the period.
|
||||
| Useful To Me Not Useful To Me | |||||
|
SgTrader17
Elite |
07-May-2021 20:15
|
||||
|
x 0
x 1 Alert Admin |
Relax man, just a mere 5 cents drop. Will recover. Or you doubt our man here who is very confident of the big orders to be placed soon?? Must have beliefs and confident mah. Relax ... Will sure go up next week. I also added some at 0.94 today. But just 5000 shares. Relax ... Relax ...
|
||||
| Useful To Me Not Useful To Me | |||||



